Garren Hideki
- SEC CIK
- 0001854126
No open-market purchases or sales filed in the past year.
Current role at each company
- PRTA Prothena Corp Public Ltd CoChief Medical Officeras of Feb 29, 2024
- COYA Coya Therapeutics, Inc.Directoras of Jan 19, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Garren Hideki as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRTA Prothena Corp Public Ltd Co
Chief Medical Officer12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2023 (view filing) | Sep 13 | Same day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −2.00K | $55.48 | −$111.0K | −100.0%0 after | 10b5-1 |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −2.00K | $58.74 | −$117.5K | −100.0%0 after | 3 lots10b5-1 |
| Jul 12, 2023 (view filing) | Jul 12 | Same day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −2.00K | $67.51 | −$135.0K | −100.0%0 after | 2 lots10b5-1 |
| Jun 16, 2023 (view filing) | Jun 16 | Same day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −7.33K | $74.00 | −$542.5K | −100.0%0 after | 10b5-1 |
| Jun 14, 2023 (view filing) | Jun 14 | Same day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −4.67K | $74.22 | −$346.5K | −100.0%0 after | 4 lots10b5-1 |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −12.0K | $48.41 | −$580.9K | −100.0%0 after | 2 lots |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −4.00K | $62.51 | −$250.0K | −100.0%0 after | |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −4.00K | $61.90 | −$247.6K | −100.0%0 after | 2 lots |
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −4.00K | $60.90 | −$243.6K | −100.0%0 after | |
| Sep 16, 2022 (view filing) | Sep 15 | 1 day | Garren HidekiChief Medical Officer | SSaleOrdinary Shares, par value $0.01 per share | −4.00K | $30.00 | −$120.0K | −100.0%0 after |
COYA Coya Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Garren HidekiDirector | PPurchaseCommon Stock, par value $0.0001 per share | +2.00K | – | – | New position2.00K after | |
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | Garren HidekiDirector | PPurchaseCommon Stock, par value $0.0001 per share | +1.00K | – | – | –1.00K after | Derivative |